Descriptive Analysis of Dual-energy Computed Tomography Exams of Adult Patients With Gout

NCT ID: NCT05065606

Last Updated: 2021-10-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-30

Study Completion Date

2021-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective is to describe urate deposits (especially in terms of distribution and volume) in soft tissues and bone, and joint erosions and destruction, in adult patients with gout.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Gout is the result of hyperuricemia, itself a consequence of a disorder of purine metabolism. This hypuricemia can lead to the deposition of sodium urate crystals in the soft tissues. It is the deposition of sodium urate crystals in and near the joints that causes an intense local inflammatory reaction with episodes of acute joint pain, swelling and functional disability. In the long term, uratic concretions in the soft tissues (tophus) occur, the joints are destroyed (uratic arthropathies), the kidneys also (gouty nephropathy).

Dual-energy CT (Computed Tomography) is a relatively recent technique that allows the identification of certain materials through the analysis of the difference in attenuation of the material exposed to two different X-ray spectra. This technique identifies the crystalline component of tophus.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gout

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dual-energy computed tomography

Dual-energy scanner examinations stored in the PACS (medical imagery) at Lariboisière Hospital are to be analyzed retrospectively and prospectively

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than or equal to 18 years old;
* Patient with a gout according to ACR (American College of Rheumatology) criteria;
* Affiliated with a social security scheme.
* Dual-energy scanner examinations stored in the PACS at Lariboisière Hospital

Exclusion Criteria

* Pregnant or breastfeeding woman.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canon Medical Systems, USA

INDUSTRY

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Valérie BOUSSON, PUPH

Role: STUDY_DIRECTOR

APHP Lariboisière - Imagerie OstéoArticulaire,Viscérale

Valérie BOUSSON, PUPH

Role: PRINCIPAL_INVESTIGATOR

APHP Lariboisière - Imagerie OstéoArticulaire,Viscérale

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Lariboisière - Service d'Imagerie OstéoArticulaire, Viscérale et Vasculaire

Paris, , France

Site Status RECRUITING

Hôpital Lariboisière - Service de Rhumatologie

Paris, , France

Site Status RECRUITING

Hôpital Bichat - Service de Rhumatologie

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Valérie BOUSSON, PUPH

Role: CONTACT

+33(0)149959107

Valérie BOUSSON, PUPH

Role: CONTACT

+33(0)149959106

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Valérie BOUSSON, PUPH

Role: primary

+33(0)149959107

Hang-Korng Ea, PU-PH

Role: primary

Sebastien Ottaviani, PH

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APHP180476

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Improving Gout Care After an ED Visit
NCT06534554 RECRUITING NA
Gout in the ED and Improving Research Participation
NCT04075903 ACTIVE_NOT_RECRUITING NA
Time Required to Dissolve Urate Deposits
NCT06669000 NOT_YET_RECRUITING
Nurse-Led Telehealth for Gout
NCT06971146 RECRUITING NA